New Data Shows Heart Failure Treatment Guided by Daxor鈥檚 BVA-100庐 Lowers Hospital Length of Stay by 55%
Daxor Inc.New data validate the benefits of the BVA-100 diagnostic blood volume measurement test in reducing hospital length of stay (LOS) for heart failure (HF) patients. Data were presented at the Heart Failure Society of America (HFSA) Annual Scientific Meeting (ASM) 2022 鈥 which brought together the world鈥檚 leading experts in heart failure.